Galanin in pituitary adenomas

Regulatory Peptides

Volumn 117, Issue 2, 2004, Pages 127-139

  Grenbäck, Eva ^a   Bjellerup, Per ^b   Wallerman, Ella ^a   Lundblad, Lars ^b   Änggård, Anders ^b   Ericson, Kaj ^a   Åman, Katarina ^c   Landry, Marc ^d   Schmidt, Wolfgang E ^e   Hökfelt, Tomas ^c   Hulting, Anna Lena ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Clinical Chemistry ^*  (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e ST JOSEF HOSPITAL   (Germany)

Author keywords

Acromegaly; ACTH; Cushing's disease; GH; Pituitary tumor; Pro opiomelonocortin; Prolactinoma

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GALANIN; MESSENGER RNA; POLYPEPTIDE;

ADULT; AGED; ARTICLE; CELL POPULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HYPOPHYSIS TUMOR; IN SITU HYBRIDIZATION; MALE; MICROADENOMA; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0347990426     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2003.10.022     Document Type: Article

References (58)

1. Tatemoto K., Rökaeus Å., Jörnvall H., McDonald T.J., Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 164:1983;124-128.
2. Bersani M., Johnsen A.H., Højrup P., Dunning B.E., Andreasen J.J., Holst J.J. Human galanin: primary structure and identification of two molecular forms. FEBS Lett. 283:1991;189-194.
3. Evans H., Shine J. Human galanin: molecular cloning reveals a unique structure. Endocrinology. 129:1991;1682-1684.
4. McKnight G.L., Karlsen A.E., Kowalyk S., Mathewes S.L., Sheppard P.O., O'Hara P.J.et al. Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes. 41:1991;82-87.
5. Schmidt W.E., Kratzin H., Eckart K., Drevs D., Mundkowski G., Clemens A.et al. Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide. Proc. Natl. Acad. Sci. U. S. A. 88:1991;11435-11439.
6. Vrontakis M.E., Peden L.M., Duckworth M.L., Friesen H.G. Isolation and characterization of a complementary DNA (galanin) clone from estrogen-induced pituitary tumor messenger RNA. J. Biol. Chem. 262:1987;16755-16758.
7. Kaplan L.M., Gabriel S.M., Koenig J.I., Sunday M.E., Spindel E.R., Martin J.B.et al. Galanin is an estrogen-inducible secretory product of the rat anterior pituitary. Proc. Natl. Acad. Sci. U. S. A. 85:1988;7408-7412.
8. Crawley J.N. The role of galanin in feeding behaviour. Neuropeptides. 33:1999;369-375.
9. Kalra S.P., Horvath T.L. Neuroendocrine interactions between galanin, opioids, and neuropeptide Y in the control of reproduction and appetite. Ann. N. Y. Acad. Sci. 863:1998;236-240.
10. Leibowitz S. Differential functions of hypothalamic galanin cell grows in the regulation of eating and body weight. Ann. N. Y. Acad. Sci. 863:1998;206-220.
11. McDonald M.P., Gleason T.C., Robinson J.K., Crawley J. Galanin inhibits performance on rodent memory tasks. Hökfelt T., Bartfai T., Crawley J. Galanin basic research discoveries and therapeutic implications. 1998;206-220 NY Acad. Sci. New York.
12. Ögren S.-O., Schött P.A., Kehr J., Yoshitake T., Misane I., Mannström P.et al. Modulation of acetylcholine and serotonin transmission by galanin. Ann. N. Y. Acad. Sci. U. S. A. 863:1998;342-363.
13. Xu X.J., Hökfelt T., Bartfai T., Wiesenfeld-Hallin Z. Galanin and spinal nociceptive mechanisms: recent advances and therapeutic implications. Neuropeptides. 34:2000;137-147.
14. Habert-Ortoli E., Amiranoff B., Loquet I., Laburthe M., Mayaux J.F. Molecular cloning of a functonal human galanin receptor. Proc. Natl. Acad. Sci. U. S. A. 91:1994;9780-9783.
15. Branchek T.A., Smith K.E., Gerald C., Walker M.W. Galanin receptor subtypes. Trends Pharmacol. Sci. 21:2000;109-116.
16. Iismaa T.P., Shine J. Galanin and galanin receptors. Results Probl. Cell Differ. 26:1999;257-291.
17. Wynick D., Small C.J., Bacon A., Holmes F.E., Norman M., Ormandy C.J.et al. Galanin regulates prolactin release and lactotroph proliferation. Proc. Natl. Acad. Sci. U. S. A. 95:1998;12671-12676.
18. Cai A., Hayes J.D., Patel N., Hyde J.F. Targeted overexpression of galanin in lactotrophs of transgenic mice induces hyperprolactinemia and pituitary hyperplasia. Endocrinology. 140:1999;4955-4964.
19. Kokaia M., Holmberg K., Nanobashvilli A., Xu Z.-Q.D., Kokaia Z., Lendahl U.et al. Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc. Natl. Acad. Sci. U. S. A. 98:2001;14006-14011.
20. Steiner R.A., Hohmann J.G., Holmes A., Wrenn C.C., Cadd G., Jureus A.et al. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4184-4189.
21. Rökaeus Å., Melander T., Hökfelt T., Lundberg J.M., Tatemoto K., Carlquist M.et al. A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci. Lett. 47:1984;161-166.
22. Skofitsch G., Jacobowitz D.M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides. 6:1985;509-546.
23. Skofitsch G., Jacobowitz D.M. Quantitative distribution of galanin-like immunoreactivity in the rat central nervous system. Peptides. 7:1986;609-613.
24. Melander T., Hökfelt T., Rökaeus Å. Distribution of galanin-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 248:1986;475-517.
25. Bloch G.J., Butler P.C., Eckersell C.B., Mills R.H. Gonadal steroid-dependent GAL-IR cells within the medial proptic nucleus (MPN) and the stimulatory effects of GAL within the MPN on sexual behaviors. Ann. N. Y. Acad. Sci. U. S. A. 863:1998;188-205.
26. Hohmann J.G., Clifton D.K., Steiner R.A. Galanin: Analysis of its coexpression in gonadotrophin-releasing hormone and growth hormone-releasing hormone neurons. Ann. N. Y. Acad. Sci. U. S. A. 863:1998;221-235.
27. Merchenthaler I. LHRH and sexual dimorphism. Ann. N. Y. Acad. Sci. U. S. A. 863:1998;175-187.
28. Bauer F.E., Ginsberg L., Venetikou M., MacKay D.J., Burirn J.M., Bloom S.R. Growth hormone release in man induced by galanin, a new hypothalamic peptide. Lancet. 26:1986;192-195.
29. Davis T.M.E., Burrin J.M., Bloom S.R. Growth hormone release in response to GH-releasing hormone in man is 3-fold enhanced by galanin. J. Clin. Endocrinol. Metab. 65:1987;1248-1252.
30. Cimini V. Galanin inhibits ACTH release in vitro and can be demonstrated immunocytochemically in dispersed corticotrophs. Exp. Cell Res. 228:1996;212-215.
31. Giustina A., Licini M., Schettino M., Doga M., Pizzocolo G., Negro-Villar A. Physiological role of galanin in the regulation of anterior pituitary function in humans. Am. J. Physiol. 266:1994;E57-E61.
32. Hooi S.C., Maiter D.M., Martin J.B., Koenig J.I. Galaninergic mechanisms are involved in the regulation of corticotropin and thyrotropin secretion in the rat. Endocrinology. 127:1990;2281-2289.
33. Hooi S.C., Koenig J.L., Gabriel S.M., Maiter D., Martin J.B. Influence of thyroid hormone on the concentration of galanin in the rat brain and pituitary. Neuroendocrinology. 51:1990;351-356.
34. Wynick D., Smith D.M., Ghatei M., Akinsanya K., Bhogal R., Purkiss P.et al. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: Absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. Proc. Natl. Acad. Sci. U. S. A. 90:1993;4231-4235.
35. Wynick D., Hammond P.J., Akinsanya K.O., Bloom S.R. Galanin regulates basal and oestrogen-stimulated lactotroph function. Nature. 364:1993;529-532.
36. Moore J.P.J., Morrison D.G., Hyde J.F. Galanin gene expression is increased in the anterior pituitary gland of the human growth hormone-releasing hormone transgenic mice. Endocrinology. 134:1994;2005-2010.
37. Hulting A.-L., Meister B., Grimelius L., Wersäll J., Änggård A., Hökfelt T. Production of a galanin-like peptide by a human pituitary adenoma: immunohistochemical evidence. Acta. Physiol. Scand. 137:1989;561-562.
38. Vrontakis M.E., Sano T., Kovacs K., Friesen H.G. Presence of galanin-like immunoreactivity in non-tumourous corticotrophs and corticotroph adenomas of the human pituitary. J. Clin. Endocrinol. Metab. 70:1990;747-751.
39. Bennet W.M., Hill S.F., Ghatei M.A., Bloom S.R. Galanin in the normal pituitary and brain and in pituitary adenomas. J. Endocrinol. 130:1991;463-467.
40. Hsu D.W., Hooi S.C., Hedley-Whyte T., Strauss R.M., Kaplan L.M. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas. Am. J. Pathol. 138:1991;897-909.
41. Polak J.M., Gibson S., Gentleman S., Steel J., Van Noorden S. Galanin: distribution, ontogeny and expression following manipulation of the endocrine and nervous system. Hökfelt T., Bartfai T., Jacobowitz D., Ottoson D. Galanin a new multifunctional peptide in the neuro-endocrine system. 1:1991;117-134 Macmillan, London.
42. Sano T., Vrontakis M.E., Kovacs K., Asa S.L., Friesen H.G. Galanin immunoreactivity in neuroendocrine tumors. Arch. Pathol. Lab. Med. 115:1991;926-929.
43. Invitti C., Pecori F., Girakldi P., Dubini A., Moroni P., Losa M.et al. Galanin is released by adrenocorticotropin-secreting pituitary adenomas in vivo and in vitro. J. Clin. Endocrinol. Metab. 4:1999;1351-1356.
44. Leung B., Iismaa T.P., Leung K.-C., Hort Y.J., Turner J., Sheehy J.P.et al. Galanin in human pituitary adenomas: frequency and clinical significance. Clin. Endocrinol. 56:2002;397-403.
45. Grenbäck E., Bjellerup P., Hulting A.-L., Lundblad L., Änggård A. Galanin i hypofysadenom. Proc. Ann. Meeting Swedish Med. Soc. 29P:1997;162.
46. P. Lundin, Magnetic resonance imaging of pituitary macroadenomas. Thesis, Uppsala ISBN 91-628-0511-8 1992.
47. Wilson C.B. A decade of pituitary microsurgery. The Herbert Olivecrona lecture. J. Neurosurg. 61:1984;814-833.
48. Schmidt W.E., Siegel E.G., Lamberts R., Gallwitz B., Creutzfeldt W. Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues. Endocrinology. 123:1988;1395-1404.
49. Drouin J., Goodman H.M. Most of the coding region of rat ACTH beta-LPH precursor gene lacks intervening sequences. Nature. 288:1980;610-613.
50. Dagerlind Å., Friberg K., Bean A., Hökfelt T. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry. 98:1992;39-49.
51. Schmitz G.G., Walter T., Seibl R., Kessler C. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Ann. Biochem. 192:1991;222-231.
52. Broberger C., Landry M., Wong H., Walsh J., Hökfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in proopiomelanocortin and neuropeptide Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology. 66:1997;393-408.
53. Aguilera G., Rabadan-Diehl C., Nikodemova M. Regulation of pituitary corticotropin releasing hormone receptors. Peptides. 22:2001;769-774.
54. Ceresini G., Freddi M., Paccotti P., Valenti G., Merchenthaler I. Effects of ovine corticotropin-releasing hormone injection and desmopressin coadministration on galanin and adrenotropin plasma levels in normal women. J. Clin. Endocrinol. Metab. 82:1997;607-610.
55. Ceresini G., Marchini L., Fabbo A., Freddi M., Pasolini G., Reali N.et al. Evaluation of circulating galanin levels after exercise-induced pituitary hormone secretion in man. Metabolism. 1997;282-286.
56. Land T., Langel U., Bartfai T. Hypothalamic degradation of galanin (1-29) and galanin (1-16): identification and characterization of the peptidolytic products. Brain Res. 558:1991;245-250.
57. Bedecs K., Langel Ü., Xu X.-J., Wiesenfeld-Hallin Z., Bartfai T. Biological activities of two endogenously occurring N-terminally extended forms of galanin in the rat spinal cord. Eur. J. Pharmacol. 259:1994;151-156.
58. Bauer F.E., Hacker G.W., Terenghi G., Adrian T.E., Polak J.M., Bloom S.R. Localization and molecular forms of galanin in human adrenals: elevated levels in pheochromocytomas. J. Clin. Endocrinol. Metab. 63:1986;1372.